Sponsor or institution

Clinical trials and research at Arcutis Biotherapeutics, Inc.

• 2Clinical trials
• 1New in 30 days
• 1Country

All recruiting trials (2)

• Roflumilast Cream 0.3% for moderate to severe atopic dermatitis in children, adolescents, and adults

  A cream called roflumilast 0.3% is tested once daily to see if it helps people with moderate to severe atopic dermatitis, compared to a non-medicated cream, across ages 6 and up.

  Recruiting at 4 sites Phase 3 Arcutis Biotherapeutics, Inc. · Birmingham, Alabama and 3 other locations · NCT07916480

• ARQ-234 single and multiple rising dose testing

  This will test different single and repeated doses of ARQ-234 to see if they are safe and how the drug behaves in healthy adults and adults with moderate-to-severe atopic dermatitis.

  Recruiting at 7 sites Phase 1 Arcutis Biotherapeutics, Inc. · Miami, Florida and 6 other locations · NCT07453602

Quick answers

How many clinical trials run by Arcutis Biotherapeutics, Inc. are recruiting right now?

2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →